Test Price
2,800 AEDโ Home Collection Available
FGFR2 Gene Antley-Bixler Syndrome Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139)
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM)
Clinical Guidance: Post-test Telephonic Guidance with a DHA-Licensed Geneticist
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
Test Overview & Methodology
This next-generation sequencing test comprehensively analyzes the FGFR2 gene for pathogenic variants causing Antley-Bixler syndrome and overlapping craniosynostosis disorders. Performed in our ISO 9001:2015-certified UAE facility, it delivers definitive molecular diagnosis within 3โ4 weeks, aiding timely surgical and developmental planning for infants and children.
| Feature | Our Test (NGS) | Alternative (Sanger) |
|---|---|---|
| Methodology | Next-Generation Sequencing (full gene, high depth) | Sanger sequencing (selected exons only) |
| Diagnostic Sensitivity | 99.9% | ~90% |
| Turnaround Time | 3โ4 Weeks | 4โ6 Weeks |
| Sample Types | Whole Blood, Extracted DNA, Dried Blood Spot (FTA) | Whole Blood or DNA only |
| UAE DHA Recognised | โ Yes | Sometimes |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (DHA Registration ID: 9294403), Consultant Medical Genetics, advises: โA positive FGFR2 result must be correlated with clinical and radiographic findings to guide craniofacial surgery and developmental support. I urge families to discuss all genetic results with a DHA-licensed geneticist to understand recurrence risks and family planning options. Never alter any prescribed therapy without your treating physicianโs guidance.โ
Advisory Precautions
- Informed consent must be obtained from the patient or legal guardian (parental consent mandatory for minors per Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Patients on anticoagulant therapy should consult their physician before venipuncture; a dry blood spot (FTA) alternative may be arranged.
- If acute medical instability is present (e.g., uncontrolled seizures, respiratory failure), stabilise the patient before sample collection.
Exclusion Criteria
- Inability to provide informed consent from patient or legal representative.
- Severe bleeding diathesis or current anticoagulation that precludes safe venipuncture when FTA card alternative is unavailable.
- Emergency red flags: infant with bulging fontanelle, projectile vomiting, lethargy, severe breathing difficulty, or cyanosis โ seek immediate emergency care before scheduling genetic testing.
Patient FAQ & Clinical Guidance
1. What does the FGFR2 NGS test detect and why is it important for my child?
This test detects mutations in the entire FGFR2 gene that cause Antley-Bixler syndrome and other craniosynostosis disorders, enabling precise diagnosis and tailored surgical planning. Early molecular confirmation helps prevent complications such as developmental delay and respiratory issues by guiding timely craniofacial interventions. In the UAE, all paediatric cases must be accompanied by a mandatory genetic counselling session and signed parental consent.
2. How is the sample collected and what happens after my blood draw?
A DHA-licensed phlebotomist collects a small blood sample or dry blood spot at your home between 8 AM and 11 PM, then transports it in an ISO-certified cold-chain system to our lab. DNA is extracted and sequenced using next-generation technology; results are then interpreted by a clinical geneticist who reviews the findings with you by phone. All data is stored in compliance with UAE PDPL regulations.
3. How do I interpret my childโs genetic test result and what are the next steps?
A positive result confirms the diagnosis and directs multidisciplinary care including neurosurgery, orthopaedics, and developmental paediatrics; a negative result may require further genetic workup. Regardless of the outcome, a post-test telephonic consultation with our geneticist explains the implications for treatment and family screening. Do not attempt to interpret results alone โ always involve your referring physician.
UAE Regulatory & Data Privacy Adherence
This test is performed under the regulatory framework of the Dubai Health Authority (DHA) and complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is handled confidentially, with explicit patient consent required prior to testing and data processing. Our DHA-licensed facility ensures strict adherence to medical liability standards as outlined in Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | FGFR2 Gene Antley-Bixler Syndrome Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3โ4 weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card) |
| Methodology Used | Next-Generation Sequencing (NGS) โ full FGFR2 gene analysis |
| ICD-10-CM Code | Q87.0 |
| LOINC Code | 78990-8 |
| DHA Facility License & Address | DHA Facility License: 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians